CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 109.00% for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-09.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2022-11-09
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2021-03-31 was 107.00%, a 33.75% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2020-03-31 was 80.00%, a 5.26% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2019-03-31 was 76.00%, a 15.15% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2018-03-31 was 66.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month |
|---|---|---|---|---|---|
| 2021-09-30 | 109.00% 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | 107.00% 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 107.00% 10-Q · filed 2022-05-05 | ||||
| 2020-09-30 | 81.00% 10-Q · filed 2021-11-09 | ||||
| 2020-06-30 | 81.00% 10-Q · filed 2021-08-03 | ||||
| 2020-03-31 | 80.00% 10-Q · filed 2021-05-12 | ||||
| 2019-09-30 | 79.00% 10-Q · filed 2020-11-10 | ||||
| 2019-06-30 | 79.00% 10-Q · filed 2020-08-04 | ||||
| 2019-03-31 | 76.00% 10-Q · filed 2020-05-12 | ||||
| 2018-03-31 | 66.00% 10-Q · filed 2019-05-14 | ||||
| 2014-06-02 | 65.00% 10-K · filed 2018-03-08 | ||||
| 2014-03-31 | 71.00% 10-Q · filed 2015-05-07 | ||||
| 2014-02-18 | 70.00% 10-K · filed 2018-03-08 | 70.00% 10-Q · filed 2014-05-09 | |||
| 2012-03-31 | 76.00% 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |